![]()
03.09.20151565
The early addition of aldosterone inhibition to standard care for patients with acute MI without HF did not reduce the risk for adverse outcomes, according to results from the ALBATROSS study presented at the European Society of Cardiology Congress.
![]()
02.09.20151798
Chief Medical Editor of Cardiology Today’s Intervention, discusses results of the OPTIDUAL Hot Line trial of dual antiplatelet therapy after drug-eluting stent implantation and provides his opinion on future research to determine the optimal duration of therapy in this population.
![]()
02.09.20151591
Use of thrombectomy to retrieve larger thrombi improved neurological recovery at discharge in patients with acute ischemic stroke, according to a substudy of the MR CLEAN trial.
![]()
31.08.20154553
RSC Board of Educational programmes together with European Society of Cardiology releases ESC webinars with Russian subtitles.
![]()
31.08.20151274
Deterioration of renal function, and an increase in related adverse events, may not be unusual in patients with nonvalvular atrial fibrillation prescribed nonvitamin K antagonist oral anticoagulants, according to recent study results in Heart and Vessels.
![]()
28.08.20151729
Cardiology Today has compiled coverage of major anticoagulation research recently published in journals, offering clinicians an overview of where the field stands in the use and effects of various therapies to manage CVD.
![]()
27.08.20151767
Published data from the HARMONY trial confirm a previous report that moderate-dose ranolazine plus reduced-dose dronedarone was well-tolerated and reduced atrial fibrillation burden, according to a report in Circulation: Arrhythmia & Electrophysiology.
